|
Aged
Garlic Extract
Studies have suggested that Aged Garlic Extract and its constituents may
improve memory and learning,1-5 enhance the growth of nerves
and/or prolong their survival,5,6 and protect the brain from
oxidative damage.7 Aged garlic extract may also help to improve
survival, according to recent studies.1,2,4,6
Choline
Studies have found that choline (from lecithin) is an important building
block for all cell membranes and it may provide an essential part of the
neurotransmitter (acetylcholine).8-10 By providing nutritional
support for the neurovascular system, studies have suggested that choline
may help to support memory and learning.8,10-13
Ginkgo biloba
The Ginkgo biloba extract in
Neuro·Logic is a potent 50:1 standardized extract containing 24%
ginkgo flavone glycosides and 6% terpene lactones. Studies have suggested
that Ginkgo biloba Extract may enhance memory and cognitive function
through stimulation of microcirculation14-34 and protect nerves
from oxidative damage.31,35-42
Carnitine
Carnitine is essential for fatty acid metabolism and for energy production.43
Acetyl-L-Carnitine may provide nutritional support for the nervous system,
especially during stress and aging, and various conditions which induce
neuronal damage.44-54
Phosphatidylserine
Phosphatidylserine has been shown to improve memory in elderly persons in
two multi-center studies55-56 and in various double-blind
studies.57-59
Folic acid
Folic acid is needed to make RNA an DNA which is vital to all cells. It is
critical for the synthesis of red blood cells. A deficiency can cause mental
confusion, anemia, and problems with nerve function.60,61 Studies
suggest that folic acid may provide nutritional support for the proper
development of the nervous system of embryos in their developmental stage,
thus preventing neural tube defects.62-64
Vitamin B12
Vitamin B12 is necessary for maintaining healthy blood cells and
nerves and for releasing energy from fats and carbohydrates.65
References
1. Moriguchi T et al.1994. In: The SAM Model of Senescence, (Takeda, T.
ed.), pp. 447-450. Elsevier Science B.V.
2. Moriguchi T et al. 1994. Biol. Pharm. Bull. 17(12): 1589-1594.
3. Zhang Y et al. 1994. In: The SAM Model of Senescence, (Takeda, T. ed.),
pp. 451-454. Elsevier Science B.V.
4. Moriguchi T et al. 1996. Biol Pharm Bull 19(2): 305-307.
5. Moriguchi T et al. 1996. Phytother. Res. 10: 468-472.
6. Nishiyama N et al. 1996. Int. Acad. Biomed. Drug Res. Basel. Karger. 11:
253-258.
7. Numagami, Y et al 1996. Neurochem. Int. 29(20): 135-143.
8. Zeisel SE. Broquist HP. 1988. "Vitamin-like" molecules. (A) Choline. In:
Shils ME, Young RV, eds. Modern Nutrition in Health and Disease, 7th ed.
Philadelphia: Lea & Febiger, 440-452.
9. Wurtman, RJ and Hirsch MJ. Lancet July 9, 1977: 68-69.
10. Sitaram, N. et al. Life Science 22: 1555-1560, 1978.
11. Bartus RT, et al. 1980. Science 209: 301-303.
12. Zeisel S et al. 1981. Cholinergic neurones and memory. Nature 293:
187-188.
13. Allain H et al. Clin Ther 15(3): 549-558, 1993.
14. Allard M. In: Advances in Ginkgo Biloba Extract Research. Effects of
Ginkgo Biloba Extract (EGb 761) on the Central Nervous System, (Christen Y,
Costnetin J and Lacour, M eds.), 1992, Elsevier Science, Paris, pp. 147-157.
15. Blavet N. In: Advances in Ginkgo Biloba Extract Research. Effects of
Ginkgo Biloba Extract (EGb 761) on the Central Nervous System, (Christen Y,
Costnetin J and Lacour, M eds.), 1992, Elsevier Science, Paris, pp. 119-127.
16. Borzeix MG. In: Effects of Ginkgo Biloba Extract on Organic Cerebral
Impairment. A. Agnoli, J.R. Rapin, V. Scapagnini, and W. V. Weitbrecht.
John
Libbey Eurotext Ltd. 1985.
17. Boyd WD et al. 1977. Lancet October 1, 1977, p. 711.
18. Brailowsky S et el. In: Advances in Ginkgo Biloba Extract Research.
Effects of Ginkgo Biloba Extract (EGb 761) on the Central Nervous System,
(Christen Y, Costnetin J and Lacour, M eds.), 1992, Elsevier Science, Paris,
pp. 105-112.
19. Bustany P et al. In: Advances in Ginkgo Biloba Extract Research. Effects
of Ginkgo Biloba Extract (EGb 761) on the Central Nervous System,
(Christen Y, Costnetin J and Lacour, M eds.), 1992, Elsevier Science, Paris,
pp. 57-74.
20. Changxun C et al. Chung Kuo Chung Yao Tsa Chih 16(11): 681-683, 704,
1991. (abs.)
21. Choussat H et al.. Geriatrie, November 1977, pp 370-375.
22. Continella G and Drago F. In: Effects of Ginkgo Biloba Extract on
Organic Cerebral Impairment. A. Agnoli, J.R. Rapin, V. Scapagnini, and W.
V.
Weitbrecht. John Libbey Eurotext Ltd. 1985.
23. Eckmann VF. Fortschr. Med. 108(29): 557-560, 1990. (German)
24. Hindmarch I. Presse Med 15(31): 1592-1594, 1986.
25. Hindmarch I. Funfgeld EW. ed. Springer-Verlag, New York, NY, pp.321-326,
1988.
26. Hofferberth B. Arzneim.-Forsch./Drug Res. 39(8): 918-922, 1989.
27. Lacour M et al. In: Advances in Ginkgo Biloba Extract Research. Effects
of Ginkgo Biloba Extract (EGb 761) on the Central Nervous System,
(Christen Y, Costnetin J and Lacour, M eds.), 1992, Elsevier Science, Paris,
pp. 37-56.
28. Le Poncin-Lafitte M et al. 1982.Cerebral ischemia after ligature of both
carotid arteries in rats: effects of Ginkgo biloba extracts. Sem. Hdp.
Paris
58(7): 403-406.(in French).
29. Michel PF. In: Advances in Ginkgo Biloba Extract Research. Effects of
Ginkgo Biloba Extract on Organic Cerebral Impairment (Agnoli, J., R., Rapin,
V., Scapagnini, W. V., & Weitbrecht, W. V.) John Libbey Eurotext Ltd., 1985.
30. Pidoux B. In: R?ken (Ginkgo Biloba) - Recent Results in Pharmacology and
Clinic. Funfgeld EW. ed. Springer-Verlag, New York, NY, pp.314-320,
1988.
31. Porsolt RD et al. In: Advances in Ginkgo Biloba Extract Research.
Effects of Ginkgo Biloba Extract (EGb 761) on the Central Nervous System,
(Christen Y, Costnetin J and Lacour, M eds.), 1992, Elsevier Science, Paris,
pp. 135-142.
32. Raffalli-SJbille MJ et al. In: Advances in Ginkgo Biloba Extract
Research. Effects of Ginkgo Biloba Extract(EGb 761) on the Central Nervous
System,
(Christen Y, Costnetin J and Lacour, M eds.), 1992, Elsevier Science, Paris,
pp. 129-134.
33. Rai GS et al. Curr Med Res Opin 12(6): 350-355, 1991.
34. Ramassamy C et al. In: Advances in Ginkgo Biloba Extract Research.
Effects of Ginkgo Biloba Extract (EGb 761) on the Central Nervous System,
(Christen Y, Costnetin J and Lacour, M eds.), 1992, Elsevier Science, Paris,
pp. 27-36.
35. Spinnewyn B. In: Advances in Ginkgo Biloba Extract Research. Effects of
Ginkgo Biloba Extract (EGb 761) on the Central Nervous System, (Christen
Y, Costnetin J and Lacour, M eds.), 1992, Elsevier Science, Paris, pp.
113-118.
36. Stein DG and Hoffman SW. In: Advances in Ginkgo Biloba Extract Research.
Effects of Ginkgo Biloba Extract (EGb 761) on the Central Nervous
System, (Christen Y, Costnetin J and Lacour, M eds.), 1992, Elsevier
Science, Paris, pp. 95-103.
37. Subhan Z and Hindmarch I. Int. J. Clin. Pharm. Res IV(2): 89-93, 1984.
38. Taylor JE. In: Effects of Ginkgo Biloba Extract on Organic Cerebral
Impairment. A. Agnoli, J.R. Rapin, V. Scapagnini, and W. V. Weitbrecht.
John
Libbey Eurotext Ltd. 1985.
39. Warburton DM. Presse Med 15(31): 1595-1604, 1986.
40. Weitbrecht WV and Jansen W. In: Effects of Ginkgo Biloba Extract on
Organic Cerebral Impairment (Agnoli, J., R., Rapin, V., Scapagnini, W. V.,
&
Weitbrecht, W. V.) John Libbey Eurotext Ltd., 1985, p. 91-99.
41. Winter E. Pharmacol. Biochem. Behavior 38: 109-114, 1991.
42. Yabe T et al. In: Advances in Ginkgo Biloba Extract Research. Effects of
Ginkgo Biloba Extract (EGb 761) on the Central Nervous System, (Christen
Y, Costnetin J and Lacour, M eds.), 1992, Elsevier Science, Paris, pp.
75-87.
43. National Academy of Sciences. 1989. RDA. 10th Ed., pp. 265-266.
44. Broquist HP. 1988. "Vitamin-like" molecules. (B) Carnitine. In: Shils
ME, Young RV, eds. Modern Nutrition in Health and Disease, 7th ed.
Philadelphia:
Lea & Febiger, 453-458.
45. Calvani M et al. 1990. New Trends in Diagnosis and Therapy 603-622.
46. Bowman B. 1990. Nutr. Rev. 50(5): 142-144.
47. Nappi G et al. 1988. Med. Sci Res. 16: 291-292.
48. De Grandis et al. 1995. Clin. Drug Invest. 10(6): 317-322.
49. Sima A. et al. 1996. J. Clin. Invest. 97(8): 1900-1907.
50. Cotter M et al. 1995. Metabolism. 44(9): 1209-1214.
51. Malone J et al. 1996. Metabolism 45(7): 902-907.
52. Bertoni-Freddari C et al. 1994. Brain Res 656: 359-366.
53. Monti D et al. 1992. Am J. Clin. Nutr. 55: 1208S-12114S.
54. Shinenaga MK et al. 1994. Proc. Natl. Acad. Sci 91: 10771-10778.
55. Crook TH, et al. 1991. Neurol 41: 644-649.
56. Crook TH et al. 1992. Psychopharmacol. 28:61-66.
57. Palmieri G et al. 1987. Clin. Trials 24: 73-83.
58. Cenacchi T et al.1993. Aging Clin. Exp. Res. 5: 123-133.
59. Delwaide PJ et al. 1986. Acta Neurol. Scand. 73: 136-140.
60. Wardlaw GM and Insel PM, eds.1993. Perspectives in Nutrtion.2nd Edition.
Mosby. St. Louis, MO, pp.396-398.
61. RDA, pp. 150-158.
62. Hibbard ED, Smithes RW. 1965. Lancet 1:1254.
63. Morb Mortal Wkly Rep. 41: RR-14, 1992.
64. Czeizel AE, Dudas I. 1992. N. Engl. J. Med. 327: 1832.
65. RDA, pp. 158-165.
|